CD8A and diffuse large B-cell lymphoma: We next assessed whether this inhibition was antigen dependent by adapting our triple-culture assay to incorporate OVA-specific OT-I CD8+ T cells interacting with OVA-loaded DLBCL-FRCs, prior to the addition of OVA-loaded DLBCL cells.